Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 7, 2014, Pages 1111-1116

  Botticella, Angela ^a   Guarneri, Alessia ^a   Levra, Niccolo Giai ^a   Munoz, Fernando ^a   Filippi, Andrea Riccardo ^a   Rondi, Nadia ^a   Badellino, Serena ^a   Arcadipane, Francesca ^a   Levis, Mario ^a   Ragona, Riccardo ^a   Ricardi, Umberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

High dose external beam radiotherapy; Nadir PSA; Prostate cancer; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOCHEMISTRY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHOTON THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION RESPONSE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL TIME; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84904123789     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1673-8     Document Type: Article

References (17)

1. Bernard JR Jr, Buskirk SJ, Heckman MG et al (2010) Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: doseresponse analysis. Int J Radiat Oncol Biol Phys 76:735-740. doi:10.1016/j.ijrobp.2009.02.049
2. Cozzarini C, Bolognesi A, Ceresoli GL et al (2004) Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 59:674-683 (Pubitemid 38748732)
3. Goenka A, Magsanoc JM, Pei X et al (2012) Long-term outcomes after high-dose post prostatectomy salvage radiation treatment. Int J Radiat Oncol Biol Phys 84:112-118. doi:10.1016/j.ijrobp.2011.10.077
4. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169:517-523 (Pubitemid 36132976)
5. King CR (2012) The timing of salvage radiotherapy after radical prostatectomy: a systematic review. Int J Radiat Oncol Biol Phys 84:104-111. doi:10.1016/j.ijrobp.2011.10.069
6. King CR, Kapp DS (2008) Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71:346-350. doi:10.1016/j.ijrobp.2007.10.008
7. King CR, Spiotto MT (2008) Improved outcomes with higher doses for salvage radiotherapy after prostatectomy. Int J Radiat Oncol Biol Phys 71:23-27. doi:10.1016/j.ijrobp.2007.09.047
8. Ko EC, Stone N, Stock RG (2012) PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. Int J Radiat Oncol Biol Phys 83:600-607. doi:10.1016/j.ijrobp.2011.07.009
9. Ohri N, Dicker AP, Trabulsi EJ, Showalter TN (2012) Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. Eur J Cancer 48:837-844. doi:10.1016/j.ejca.2011.08. 013
10. Ost P, Cozzarini C, De Meerleer G et al (2012) High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy. Int J Radiat Oncol Biol Phys 83:960-965. doi:10.1016/j.ijrobp.2011.09. 007
11. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-1597 (Pubitemid 29211767)
12. Ray ME, Thames HD, Levy LB et al (2006) PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 64:1140-1150
13. Siegmann A, Bottke D, Faehndrich J et al (2011) Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study. Strahlenther Onkol 187:467-472. doi:10.1007/s00066-011- 2229-3
14. Stephenson AJ, Scardino PT, Kattan MW et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035-2041 (Pubitemid 46972788)
15. Swanson GP, Hussey MA, Tangen CM et al (2007) Predominant treatment failure in post- prostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 25:2225-2229 (Pubitemid 46954647)
16. Thompson IM, Valicenti RK, Albertsen P et al (2013) Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol 190(2):441-449. doi:10.1016/j.juro.2013.05.032
17. Wiegel T, Lohm G, Bottke D et al (2009) Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome-results of a retrospective study. Int J Radiat Oncol Biol Phys 73:1009-1016. doi:10.1016/j.ijrobp.2008.06.1922